|
Name |
(1R,3S,4R,7R,8R,10S,11R,14R)-5,12-bis[(E)-1-hydroxyhex-4-enyl]-3,7,10,14-tetramethyl-2,9-dioxapentacyclo[8.4.0.03,8.04,14.07,11]tetradeca-5,12-diene-1,6,8,13-tetrol
|
| Molecular Formula | C28H40O8 | |
| IUPAC Name* |
(1R,3S,4R,7R,8R,10S,11R,14R)-5,12-bis[(E)-1-hydroxyhex-4-enyl]-3,7,10,14-tetramethyl-2,9-dioxapentacyclo[8.4.0.03,8.04,14.07,11]tetradeca-5,12-diene-1,6,8,13-tetrol
|
|
| SMILES |
C/C=C/CCC(O)C1=C([C@@]2([C@]3(O[C@]4([C@@H]2C(=C([C@@]5([C@]4(O[C@]3([C@H]15)C)O)C)O)C(O)CC/C=C/C)C)O)C)O
|
|
| InChI |
InChI=1S/C28H40O8/c1-7-9-11-13-15(29)17-19-23(3)22(32)18(16(30)14-12-10-8-2)20-24(4,21(17)31)28(34)25(19,5)35-27(23,33)26(20,6)36-28/h7-10,15-16,19-20,29-34H,11-14H2,1-6H3/b9-7+,10-8+/t15?,16?,19-,20-,23-,24-,25+,26+,27-,28-/m1/s1
|
|
| InChIKey |
MWPHVHVJTFWJNQ-MIYXZYPXSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | 101775643 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 504.6 | ALogp: | 1.5 |
| HBD: | 6 | HBA: | 8 |
| Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 140.0 | Aromatic Rings: | 5 |
| Heavy Atoms: | 36 | QED Weighted: | 0.272 |
| Caco-2 Permeability: | -5.522 | MDCK Permeability: | 0.00003940 |
| Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.945 |
| Human Intestinal Absorption (HIA): | 0.947 | 20% Bioavailability (F20%): | 0.918 |
| 30% Bioavailability (F30%): | 0.868 |
| Blood-Brain-Barrier Penetration (BBB): | 0.819 | Plasma Protein Binding (PPB): | 89.08% |
| Volume Distribution (VD): | 0.712 | Fu: | 7.69% |
| CYP1A2-inhibitor: | 0.003 | CYP1A2-substrate: | 0.955 |
| CYP2C19-inhibitor: | 0.014 | CYP2C19-substrate: | 0.825 |
| CYP2C9-inhibitor: | 0.004 | CYP2C9-substrate: | 0.008 |
| CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.048 |
| CYP3A4-inhibitor: | 0.258 | CYP3A4-substrate: | 0.861 |
| Clearance (CL): | 6.299 | Half-life (T1/2): | 0.117 |
| hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.373 |
| Drug-inuced Liver Injury (DILI): | 0.407 | AMES Toxicity: | 0.055 |
| Rat Oral Acute Toxicity: | 0.943 | Maximum Recommended Daily Dose: | 0.254 |
| Skin Sensitization: | 0.044 | Carcinogencity: | 0.943 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.012 |
| Respiratory Toxicity: | 0.988 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003762 | ![]() |
0.488 | D0H2MO | ![]() |
0.165 | ||
| ENC002133 | ![]() |
0.399 | D04VEJ | ![]() |
0.159 | ||
| ENC005695 | ![]() |
0.398 | D0WY9N | ![]() |
0.150 | ||
| ENC004472 | ![]() |
0.391 | D0N3NO | ![]() |
0.149 | ||
| ENC002144 | ![]() |
0.331 | D08SVH | ![]() |
0.148 | ||
| ENC004086 | ![]() |
0.326 | D0E9KA | ![]() |
0.148 | ||
| ENC003709 | ![]() |
0.301 | D02ZGI | ![]() |
0.148 | ||
| ENC005987 | ![]() |
0.289 | D02GAC | ![]() |
0.146 | ||
| ENC004085 | ![]() |
0.273 | D06FEA | ![]() |
0.146 | ||
| ENC003579 | ![]() |
0.257 | D03VFL | ![]() |
0.145 | ||